Boston Scientific Corporation
BSX
$48.31
-$0.80-1.63%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.45B | 1.97B | 1.28B | 534.00M | 725.00M |
| Total Receivables | 3.03B | 2.93B | 2.83B | 2.82B | 2.69B |
| Inventory | 3.12B | 2.94B | 2.92B | 2.86B | 2.87B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.09B | 960.00M | 1.01B | 911.00M | 1.05B |
| Total Current Assets | 8.68B | 8.79B | 8.04B | 7.12B | 7.34B |
|
|
|||||
| Total Current Assets | 8.68B | 8.79B | 8.04B | 7.12B | 7.34B |
| Net Property, Plant & Equipment | 4.61B | 4.50B | 4.29B | 3.95B | 3.84B |
| Long-term Investments | 18.54B | 18.28B | 18.21B | 18.08B | 17.34B |
| Goodwill | 18.54B | 18.28B | 18.21B | 18.08B | 17.34B |
| Total Other Intangibles | 7.06B | 7.02B | 7.16B | 7.26B | 6.57B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.76B | 4.40B | 4.36B | 4.52B | 4.41B |
| Total Assets | 44.35B | 43.67B | 42.71B | 41.56B | 40.14B |
|
|
|||||
| Total Accounts Payable | 1.14B | 1.14B | 1.00B | 962.00M | 1.00B |
| Total Accrued Expenses | 2.51B | 3.20B | 2.75B | 2.59B | 2.10B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.00M | 389.00M | 483.00M | 480.00M | 777.00M |
| Total Finance Division Other Current Liabilities | 875.00M | 705.00M | 1.09B | 1.16B | 1.17B |
| Total Other Current Liabilities | 875.00M | 705.00M | 1.09B | 1.16B | 1.17B |
| Total Current Liabilities | 4.57B | 5.44B | 5.33B | 5.19B | 5.06B |
|
|
|||||
| Total Current Liabilities | 4.57B | 5.44B | 5.33B | 5.19B | 5.06B |
| Long-Term Debt | 10.86B | 11.01B | 10.99B | 10.98B | 10.41B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 124.00M | 571.00M | 570.00M | 566.00M | 525.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.69B | 2.18B | 2.19B | 2.17B | 1.71B |
| Total Liabilities | 18.25B | 19.20B | 19.08B | 18.91B | 17.70B |
|
|
|||||
| Common Stock & APIC | 21.60B | 21.52B | 21.44B | 21.25B | 21.14B |
| Retained Earnings | 6.91B | 5.57B | 4.90B | 4.14B | 3.35B |
| Treasury Stock & Other | -2.65B | -2.86B | -2.94B | -2.97B | -2.28B |
| Total Common Equity | 25.86B | 24.23B | 23.39B | 22.42B | 22.21B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.86B | 24.23B | 23.39B | 22.42B | 22.21B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 240.00M | 239.00M | 236.00M | 235.00M | 233.00M |
| Total Equity | 26.10B | 24.47B | 23.63B | 22.65B | 22.45B |
|
|
|||||